Delivery Order SPE2DB20D3101-SPE2DB22FK4V1

Award Date 7/26/22
Potential Completion Date 7/27/22
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,629.42, is for the supply of LATUDA 40 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through July 18, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,059.66 firm fixed-price delivery order is for the supply of 4566665451 ! LATUDA 40 MG TABLET 30S, with a performance period through December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,437.89 Firm Fixed Price Delivery Order is for the supply of LATUDA 120 MG TABLET 30S, a prescription medication, with a period of performance through January 31, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,798.40, is for the delivery of Latuda 40 mg tablets. It is a firm fixed-price delivery order contract that runs through September 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LATUDA 40 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $12,312.10. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,052.39 firm fixed-price delivery order is for the supply of LATUDA 40 MG TABLET 30S, with an ultimate completion date of June 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,406.02 firm fixed-price delivery order is for the supply of LATUDA 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award has been issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,223.77, is a delivery order for the supply of LATUDA 40 MG TABLET 30S, a medication used for the treatment of mental health conditions. The award has an ultimate completion date of November 14, 2024 and is a firm fixed-price contract. There is no set-aside designation, indicating this was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,335.17 firm fixed-price delivery order is for the supply of LATUDA 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $2,222.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LATUDA 40 MG TABLET 30S, a pharmaceutical product, with a completion date of July 8, 2024. The contract is not designated as a set-aside and is a firm fixed-price contract type. AmerisourceBergen Drug Corp is the prime contractor, and the...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FK4V1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557906066 - LATUDA 40 MG TABLET 30S. The $3,021.95 firm fixed-price delivery order contract has a completion date of July 27, 2022. The contract is not designated as a set-aside.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.

Generated 2/27/25, 1:35 PM